Crossref


1. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS

- Mohamed Labib Salem

- Abdel-Aziz A. Zidan

- Mohamed Attia

- Randa E. EL-Naggar

- Mohamed Nassef

- Abdel Raouf Abou El-Azm

- Hasan El-Bate

- Mohamed Yussif

- Sohaila Galal

- Mohamed Abo Senna

- Maha El Demellawy

4. Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease

- Nurdan Guldiken

- Gokce Kobazi Ensari

- Pooja Lahiri

- Gabrielle Couchy

- Christian Preisinger

- Christian Liedtke

- Henning W. Zimmermann

- Marianne Ziol

- Peter Boor

- Jessica Zucman-Rossi

- Christian Trautwein

- Pavel Strnad

5. Impact of Treatment against Hepatitis C Virus on Overall Survival of Naive Patients with Advanced Liver Disease

- Blaise K. Kutala

- Jeremie Guedj

- Tarik Asselah

- Nathalie Boyer

- Feryel Mouri

- Michelle Martinot-Peignoux

- Dominique Valla

- Patrick Marcellin

- Xavier Duval

6. Tratamiento actual de la hepatitis C en Colombia

- Juan Ignacio Marín-Zuluaga

- Gabriel Sebastián Díaz-Ramírez

8. Treating hepatitis C in patients with hemoglobinopathies

- Roberta D’Ambrosio

- Erika Poggiali

- Maria Domenica Cappellini